Journal of Gastrointestinal Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2300654, encodeId=130723006543b, content=投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2.4 Awaiting assignment （刚投稿） 2.10 under review (step 1) （1就是交给编辑） 2.12 desk reject （原因说优先级不够，建议我转头同出版社另一个ESCI）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ea9923940, createdName=ms6000000231166199, createdTime=Fri Feb 13 17:49:04 CST 2026, time=2026-02-13, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2293103, encodeId=70a8229310345, content=偏重的研究方向：肿瘤 经验分享：接受两个月了，还没有proof..大佬们接受到proof要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e36162439, createdName=ms8000001603765264, createdTime=Sat Dec 13 14:54:10 CST 2025, time=2025-12-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240087, encodeId=105b224008ea8, content=偏重的研究方向：生信 经验分享：请问awaiting assignment这一步一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a5a9325620, createdName=ms5000000732412420, createdTime=Sat Nov 30 17:27:25 CST 2024, time=2024-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2239939, encodeId=41452239939ec, content=请问under reveiw后变成Archived是被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec1d5521477, createdName=ms8000001149447305, createdTime=Fri Nov 29 16:34:47 CST 2024, time=2024-11-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227484, encodeId=9a9d222e484fe, content=偏重的研究方向：胃癌 经验分享：修回中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73b9380744, createdName=ms5000000214083952, createdTime=Tue Sep 24 18:46:38 CST 2024, time=2024-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129427, encodeId=52a9212942ea3, content=请教大家，进入step3一个半月了突然又回到step1，这是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Sun Apr 30 14:58:22 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2090962, encodeId=8dd320909622e, content=投稿命中率:25.0 偏重的研究方向：胃癌;生信;预后标志物 经验分享：生信文章，9.22日送审，9.82号直接拒稿，编辑一审这不过，理由优先级不够, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Thu Sep 29 10:07:38 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217628, encodeId=94a9221e62862, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：三个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb86584693, createdName=ms4000001538615850, createdTime=Tue Jul 30 16:58:19 CST 2024, time=2024-07-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2118660, encodeId=d03e211866059, content=请问有最近投稿的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Fri Mar 10 14:06:32 CST 2023, time=2023-03-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2115771, encodeId=34572115e716e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间偏慢，光分配编辑就快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf85455514, createdName=ms7000001555950151, createdTime=Tue Feb 21 19:37:23 CST 2023, time=2023-02-21, status=1, ipAttribution=浙江省)]

2026-02-13 ms6000000231166199 来自河南

投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：2.4 Awaiting assignment （刚投稿）
2.10 under review (step 1) （1就是交给编辑）
2.12 desk reject （原因说优先级不够，建议我转头同出版社另一个ESCI）

24 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2300654, encodeId=130723006543b, content=投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2.4 Awaiting assignment （刚投稿） 2.10 under review (step 1) （1就是交给编辑） 2.12 desk reject （原因说优先级不够，建议我转头同出版社另一个ESCI）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ea9923940, createdName=ms6000000231166199, createdTime=Fri Feb 13 17:49:04 CST 2026, time=2026-02-13, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2293103, encodeId=70a8229310345, content=偏重的研究方向：肿瘤 经验分享：接受两个月了，还没有proof..大佬们接受到proof要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e36162439, createdName=ms8000001603765264, createdTime=Sat Dec 13 14:54:10 CST 2025, time=2025-12-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240087, encodeId=105b224008ea8, content=偏重的研究方向：生信 经验分享：请问awaiting assignment这一步一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a5a9325620, createdName=ms5000000732412420, createdTime=Sat Nov 30 17:27:25 CST 2024, time=2024-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2239939, encodeId=41452239939ec, content=请问under reveiw后变成Archived是被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec1d5521477, createdName=ms8000001149447305, createdTime=Fri Nov 29 16:34:47 CST 2024, time=2024-11-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227484, encodeId=9a9d222e484fe, content=偏重的研究方向：胃癌 经验分享：修回中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73b9380744, createdName=ms5000000214083952, createdTime=Tue Sep 24 18:46:38 CST 2024, time=2024-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129427, encodeId=52a9212942ea3, content=请教大家，进入step3一个半月了突然又回到step1，这是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Sun Apr 30 14:58:22 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2090962, encodeId=8dd320909622e, content=投稿命中率:25.0 偏重的研究方向：胃癌;生信;预后标志物 经验分享：生信文章，9.22日送审，9.82号直接拒稿，编辑一审这不过，理由优先级不够, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Thu Sep 29 10:07:38 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217628, encodeId=94a9221e62862, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：三个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb86584693, createdName=ms4000001538615850, createdTime=Tue Jul 30 16:58:19 CST 2024, time=2024-07-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2118660, encodeId=d03e211866059, content=请问有最近投稿的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Fri Mar 10 14:06:32 CST 2023, time=2023-03-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2115771, encodeId=34572115e716e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间偏慢，光分配编辑就快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf85455514, createdName=ms7000001555950151, createdTime=Tue Feb 21 19:37:23 CST 2023, time=2023-02-21, status=1, ipAttribution=浙江省)]

2025-12-13 ms8000001603765264 来自上海

偏重的研究方向：肿瘤
经验分享：接受两个月了，还没有proof..大佬们接受到proof要多久呀

37 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2300654, encodeId=130723006543b, content=投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2.4 Awaiting assignment （刚投稿） 2.10 under review (step 1) （1就是交给编辑） 2.12 desk reject （原因说优先级不够，建议我转头同出版社另一个ESCI）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ea9923940, createdName=ms6000000231166199, createdTime=Fri Feb 13 17:49:04 CST 2026, time=2026-02-13, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2293103, encodeId=70a8229310345, content=偏重的研究方向：肿瘤 经验分享：接受两个月了，还没有proof..大佬们接受到proof要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e36162439, createdName=ms8000001603765264, createdTime=Sat Dec 13 14:54:10 CST 2025, time=2025-12-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240087, encodeId=105b224008ea8, content=偏重的研究方向：生信 经验分享：请问awaiting assignment这一步一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a5a9325620, createdName=ms5000000732412420, createdTime=Sat Nov 30 17:27:25 CST 2024, time=2024-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2239939, encodeId=41452239939ec, content=请问under reveiw后变成Archived是被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec1d5521477, createdName=ms8000001149447305, createdTime=Fri Nov 29 16:34:47 CST 2024, time=2024-11-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227484, encodeId=9a9d222e484fe, content=偏重的研究方向：胃癌 经验分享：修回中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73b9380744, createdName=ms5000000214083952, createdTime=Tue Sep 24 18:46:38 CST 2024, time=2024-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129427, encodeId=52a9212942ea3, content=请教大家，进入step3一个半月了突然又回到step1，这是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Sun Apr 30 14:58:22 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2090962, encodeId=8dd320909622e, content=投稿命中率:25.0 偏重的研究方向：胃癌;生信;预后标志物 经验分享：生信文章，9.22日送审，9.82号直接拒稿，编辑一审这不过，理由优先级不够, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Thu Sep 29 10:07:38 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217628, encodeId=94a9221e62862, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：三个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb86584693, createdName=ms4000001538615850, createdTime=Tue Jul 30 16:58:19 CST 2024, time=2024-07-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2118660, encodeId=d03e211866059, content=请问有最近投稿的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Fri Mar 10 14:06:32 CST 2023, time=2023-03-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2115771, encodeId=34572115e716e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间偏慢，光分配编辑就快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf85455514, createdName=ms7000001555950151, createdTime=Tue Feb 21 19:37:23 CST 2023, time=2023-02-21, status=1, ipAttribution=浙江省)]

2024-11-30 ms5000000732412420 来自湖北省

偏重的研究方向：生信
经验分享：请问awaiting assignment这一步一般要多久啊

74 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2300654, encodeId=130723006543b, content=投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2.4 Awaiting assignment （刚投稿） 2.10 under review (step 1) （1就是交给编辑） 2.12 desk reject （原因说优先级不够，建议我转头同出版社另一个ESCI）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ea9923940, createdName=ms6000000231166199, createdTime=Fri Feb 13 17:49:04 CST 2026, time=2026-02-13, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2293103, encodeId=70a8229310345, content=偏重的研究方向：肿瘤 经验分享：接受两个月了，还没有proof..大佬们接受到proof要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e36162439, createdName=ms8000001603765264, createdTime=Sat Dec 13 14:54:10 CST 2025, time=2025-12-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240087, encodeId=105b224008ea8, content=偏重的研究方向：生信 经验分享：请问awaiting assignment这一步一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a5a9325620, createdName=ms5000000732412420, createdTime=Sat Nov 30 17:27:25 CST 2024, time=2024-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2239939, encodeId=41452239939ec, content=请问under reveiw后变成Archived是被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec1d5521477, createdName=ms8000001149447305, createdTime=Fri Nov 29 16:34:47 CST 2024, time=2024-11-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227484, encodeId=9a9d222e484fe, content=偏重的研究方向：胃癌 经验分享：修回中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73b9380744, createdName=ms5000000214083952, createdTime=Tue Sep 24 18:46:38 CST 2024, time=2024-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129427, encodeId=52a9212942ea3, content=请教大家，进入step3一个半月了突然又回到step1，这是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Sun Apr 30 14:58:22 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2090962, encodeId=8dd320909622e, content=投稿命中率:25.0 偏重的研究方向：胃癌;生信;预后标志物 经验分享：生信文章，9.22日送审，9.82号直接拒稿，编辑一审这不过，理由优先级不够, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Thu Sep 29 10:07:38 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217628, encodeId=94a9221e62862, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：三个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb86584693, createdName=ms4000001538615850, createdTime=Tue Jul 30 16:58:19 CST 2024, time=2024-07-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2118660, encodeId=d03e211866059, content=请问有最近投稿的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Fri Mar 10 14:06:32 CST 2023, time=2023-03-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2115771, encodeId=34572115e716e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间偏慢，光分配编辑就快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf85455514, createdName=ms7000001555950151, createdTime=Tue Feb 21 19:37:23 CST 2023, time=2023-02-21, status=1, ipAttribution=浙江省)]

2024-11-29 ms8000001149447305 来自上海

请问under reveiw后变成Archived是被拒稿了吗

93 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2300654, encodeId=130723006543b, content=投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2.4 Awaiting assignment （刚投稿） 2.10 under review (step 1) （1就是交给编辑） 2.12 desk reject （原因说优先级不够，建议我转头同出版社另一个ESCI）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ea9923940, createdName=ms6000000231166199, createdTime=Fri Feb 13 17:49:04 CST 2026, time=2026-02-13, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2293103, encodeId=70a8229310345, content=偏重的研究方向：肿瘤 经验分享：接受两个月了，还没有proof..大佬们接受到proof要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e36162439, createdName=ms8000001603765264, createdTime=Sat Dec 13 14:54:10 CST 2025, time=2025-12-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240087, encodeId=105b224008ea8, content=偏重的研究方向：生信 经验分享：请问awaiting assignment这一步一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a5a9325620, createdName=ms5000000732412420, createdTime=Sat Nov 30 17:27:25 CST 2024, time=2024-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2239939, encodeId=41452239939ec, content=请问under reveiw后变成Archived是被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec1d5521477, createdName=ms8000001149447305, createdTime=Fri Nov 29 16:34:47 CST 2024, time=2024-11-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227484, encodeId=9a9d222e484fe, content=偏重的研究方向：胃癌 经验分享：修回中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73b9380744, createdName=ms5000000214083952, createdTime=Tue Sep 24 18:46:38 CST 2024, time=2024-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129427, encodeId=52a9212942ea3, content=请教大家，进入step3一个半月了突然又回到step1，这是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Sun Apr 30 14:58:22 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2090962, encodeId=8dd320909622e, content=投稿命中率:25.0 偏重的研究方向：胃癌;生信;预后标志物 经验分享：生信文章，9.22日送审，9.82号直接拒稿，编辑一审这不过，理由优先级不够, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Thu Sep 29 10:07:38 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217628, encodeId=94a9221e62862, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：三个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb86584693, createdName=ms4000001538615850, createdTime=Tue Jul 30 16:58:19 CST 2024, time=2024-07-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2118660, encodeId=d03e211866059, content=请问有最近投稿的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Fri Mar 10 14:06:32 CST 2023, time=2023-03-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2115771, encodeId=34572115e716e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间偏慢，光分配编辑就快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf85455514, createdName=ms7000001555950151, createdTime=Tue Feb 21 19:37:23 CST 2023, time=2023-02-21, status=1, ipAttribution=浙江省)]

2024-09-24 ms5000000214083952

偏重的研究方向：胃癌
经验分享：修回中

85 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2300654, encodeId=130723006543b, content=投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2.4 Awaiting assignment （刚投稿） 2.10 under review (step 1) （1就是交给编辑） 2.12 desk reject （原因说优先级不够，建议我转头同出版社另一个ESCI）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ea9923940, createdName=ms6000000231166199, createdTime=Fri Feb 13 17:49:04 CST 2026, time=2026-02-13, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2293103, encodeId=70a8229310345, content=偏重的研究方向：肿瘤 经验分享：接受两个月了，还没有proof..大佬们接受到proof要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e36162439, createdName=ms8000001603765264, createdTime=Sat Dec 13 14:54:10 CST 2025, time=2025-12-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240087, encodeId=105b224008ea8, content=偏重的研究方向：生信 经验分享：请问awaiting assignment这一步一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a5a9325620, createdName=ms5000000732412420, createdTime=Sat Nov 30 17:27:25 CST 2024, time=2024-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2239939, encodeId=41452239939ec, content=请问under reveiw后变成Archived是被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec1d5521477, createdName=ms8000001149447305, createdTime=Fri Nov 29 16:34:47 CST 2024, time=2024-11-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227484, encodeId=9a9d222e484fe, content=偏重的研究方向：胃癌 经验分享：修回中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73b9380744, createdName=ms5000000214083952, createdTime=Tue Sep 24 18:46:38 CST 2024, time=2024-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129427, encodeId=52a9212942ea3, content=请教大家，进入step3一个半月了突然又回到step1，这是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Sun Apr 30 14:58:22 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2090962, encodeId=8dd320909622e, content=投稿命中率:25.0 偏重的研究方向：胃癌;生信;预后标志物 经验分享：生信文章，9.22日送审，9.82号直接拒稿，编辑一审这不过，理由优先级不够, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Thu Sep 29 10:07:38 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217628, encodeId=94a9221e62862, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：三个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb86584693, createdName=ms4000001538615850, createdTime=Tue Jul 30 16:58:19 CST 2024, time=2024-07-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2118660, encodeId=d03e211866059, content=请问有最近投稿的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Fri Mar 10 14:06:32 CST 2023, time=2023-03-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2115771, encodeId=34572115e716e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间偏慢，光分配编辑就快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf85455514, createdName=ms7000001555950151, createdTime=Tue Feb 21 19:37:23 CST 2023, time=2023-02-21, status=1, ipAttribution=浙江省)]

2023-04-30 ms6000001015003171 来自上海

请教大家，进入step3一个半月了突然又回到step1，这是什么意思呢？

191 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2300654, encodeId=130723006543b, content=投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2.4 Awaiting assignment （刚投稿） 2.10 under review (step 1) （1就是交给编辑） 2.12 desk reject （原因说优先级不够，建议我转头同出版社另一个ESCI）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ea9923940, createdName=ms6000000231166199, createdTime=Fri Feb 13 17:49:04 CST 2026, time=2026-02-13, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2293103, encodeId=70a8229310345, content=偏重的研究方向：肿瘤 经验分享：接受两个月了，还没有proof..大佬们接受到proof要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e36162439, createdName=ms8000001603765264, createdTime=Sat Dec 13 14:54:10 CST 2025, time=2025-12-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240087, encodeId=105b224008ea8, content=偏重的研究方向：生信 经验分享：请问awaiting assignment这一步一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a5a9325620, createdName=ms5000000732412420, createdTime=Sat Nov 30 17:27:25 CST 2024, time=2024-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2239939, encodeId=41452239939ec, content=请问under reveiw后变成Archived是被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec1d5521477, createdName=ms8000001149447305, createdTime=Fri Nov 29 16:34:47 CST 2024, time=2024-11-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227484, encodeId=9a9d222e484fe, content=偏重的研究方向：胃癌 经验分享：修回中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73b9380744, createdName=ms5000000214083952, createdTime=Tue Sep 24 18:46:38 CST 2024, time=2024-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129427, encodeId=52a9212942ea3, content=请教大家，进入step3一个半月了突然又回到step1，这是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Sun Apr 30 14:58:22 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2090962, encodeId=8dd320909622e, content=投稿命中率:25.0 偏重的研究方向：胃癌;生信;预后标志物 经验分享：生信文章，9.22日送审，9.82号直接拒稿，编辑一审这不过，理由优先级不够, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Thu Sep 29 10:07:38 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217628, encodeId=94a9221e62862, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：三个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb86584693, createdName=ms4000001538615850, createdTime=Tue Jul 30 16:58:19 CST 2024, time=2024-07-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2118660, encodeId=d03e211866059, content=请问有最近投稿的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Fri Mar 10 14:06:32 CST 2023, time=2023-03-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2115771, encodeId=34572115e716e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间偏慢，光分配编辑就快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf85455514, createdName=ms7000001555950151, createdTime=Tue Feb 21 19:37:23 CST 2023, time=2023-02-21, status=1, ipAttribution=浙江省)]

2022-09-29 ms2000000713462597

投稿命中率:25.0
偏重的研究方向：胃癌;生信;预后标志物
经验分享：生信文章，9.22日送审，9.82号直接拒稿，编辑一审这不过，理由优先级不够

166 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2300654, encodeId=130723006543b, content=投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2.4 Awaiting assignment （刚投稿） 2.10 under review (step 1) （1就是交给编辑） 2.12 desk reject （原因说优先级不够，建议我转头同出版社另一个ESCI）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ea9923940, createdName=ms6000000231166199, createdTime=Fri Feb 13 17:49:04 CST 2026, time=2026-02-13, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2293103, encodeId=70a8229310345, content=偏重的研究方向：肿瘤 经验分享：接受两个月了，还没有proof..大佬们接受到proof要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e36162439, createdName=ms8000001603765264, createdTime=Sat Dec 13 14:54:10 CST 2025, time=2025-12-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240087, encodeId=105b224008ea8, content=偏重的研究方向：生信 经验分享：请问awaiting assignment这一步一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a5a9325620, createdName=ms5000000732412420, createdTime=Sat Nov 30 17:27:25 CST 2024, time=2024-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2239939, encodeId=41452239939ec, content=请问under reveiw后变成Archived是被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec1d5521477, createdName=ms8000001149447305, createdTime=Fri Nov 29 16:34:47 CST 2024, time=2024-11-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227484, encodeId=9a9d222e484fe, content=偏重的研究方向：胃癌 经验分享：修回中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73b9380744, createdName=ms5000000214083952, createdTime=Tue Sep 24 18:46:38 CST 2024, time=2024-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129427, encodeId=52a9212942ea3, content=请教大家，进入step3一个半月了突然又回到step1，这是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Sun Apr 30 14:58:22 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2090962, encodeId=8dd320909622e, content=投稿命中率:25.0 偏重的研究方向：胃癌;生信;预后标志物 经验分享：生信文章，9.22日送审，9.82号直接拒稿，编辑一审这不过，理由优先级不够, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Thu Sep 29 10:07:38 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217628, encodeId=94a9221e62862, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：三个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb86584693, createdName=ms4000001538615850, createdTime=Tue Jul 30 16:58:19 CST 2024, time=2024-07-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2118660, encodeId=d03e211866059, content=请问有最近投稿的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Fri Mar 10 14:06:32 CST 2023, time=2023-03-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2115771, encodeId=34572115e716e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间偏慢，光分配编辑就快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf85455514, createdName=ms7000001555950151, createdTime=Tue Feb 21 19:37:23 CST 2023, time=2023-02-21, status=1, ipAttribution=浙江省)]

2024-07-30 ms4000001538615850 来自北京

审稿速度:3.0 | 投稿命中率:95.0
经验分享：三个月接受

132 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2300654, encodeId=130723006543b, content=投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2.4 Awaiting assignment （刚投稿） 2.10 under review (step 1) （1就是交给编辑） 2.12 desk reject （原因说优先级不够，建议我转头同出版社另一个ESCI）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ea9923940, createdName=ms6000000231166199, createdTime=Fri Feb 13 17:49:04 CST 2026, time=2026-02-13, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2293103, encodeId=70a8229310345, content=偏重的研究方向：肿瘤 经验分享：接受两个月了，还没有proof..大佬们接受到proof要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e36162439, createdName=ms8000001603765264, createdTime=Sat Dec 13 14:54:10 CST 2025, time=2025-12-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240087, encodeId=105b224008ea8, content=偏重的研究方向：生信 经验分享：请问awaiting assignment这一步一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a5a9325620, createdName=ms5000000732412420, createdTime=Sat Nov 30 17:27:25 CST 2024, time=2024-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2239939, encodeId=41452239939ec, content=请问under reveiw后变成Archived是被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec1d5521477, createdName=ms8000001149447305, createdTime=Fri Nov 29 16:34:47 CST 2024, time=2024-11-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227484, encodeId=9a9d222e484fe, content=偏重的研究方向：胃癌 经验分享：修回中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73b9380744, createdName=ms5000000214083952, createdTime=Tue Sep 24 18:46:38 CST 2024, time=2024-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129427, encodeId=52a9212942ea3, content=请教大家，进入step3一个半月了突然又回到step1，这是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Sun Apr 30 14:58:22 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2090962, encodeId=8dd320909622e, content=投稿命中率:25.0 偏重的研究方向：胃癌;生信;预后标志物 经验分享：生信文章，9.22日送审，9.82号直接拒稿，编辑一审这不过，理由优先级不够, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Thu Sep 29 10:07:38 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217628, encodeId=94a9221e62862, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：三个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb86584693, createdName=ms4000001538615850, createdTime=Tue Jul 30 16:58:19 CST 2024, time=2024-07-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2118660, encodeId=d03e211866059, content=请问有最近投稿的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Fri Mar 10 14:06:32 CST 2023, time=2023-03-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2115771, encodeId=34572115e716e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间偏慢，光分配编辑就快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf85455514, createdName=ms7000001555950151, createdTime=Tue Feb 21 19:37:23 CST 2023, time=2023-02-21, status=1, ipAttribution=浙江省)]

2023-03-10 ms6000001015003171 来自上海

请问有最近投稿的小伙伴吗?

186 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2300654, encodeId=130723006543b, content=投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：2.4 Awaiting assignment （刚投稿） 2.10 under review (step 1) （1就是交给编辑） 2.12 desk reject （原因说优先级不够，建议我转头同出版社另一个ESCI）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ea9923940, createdName=ms6000000231166199, createdTime=Fri Feb 13 17:49:04 CST 2026, time=2026-02-13, status=1, ipAttribution=河南), GetPortalCommentsPageByObjectIdResponse(id=2293103, encodeId=70a8229310345, content=偏重的研究方向：肿瘤 经验分享：接受两个月了，还没有proof..大佬们接受到proof要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e36162439, createdName=ms8000001603765264, createdTime=Sat Dec 13 14:54:10 CST 2025, time=2025-12-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240087, encodeId=105b224008ea8, content=偏重的研究方向：生信 经验分享：请问awaiting assignment这一步一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a5a9325620, createdName=ms5000000732412420, createdTime=Sat Nov 30 17:27:25 CST 2024, time=2024-11-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2239939, encodeId=41452239939ec, content=请问under reveiw后变成Archived是被拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ec1d5521477, createdName=ms8000001149447305, createdTime=Fri Nov 29 16:34:47 CST 2024, time=2024-11-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2227484, encodeId=9a9d222e484fe, content=偏重的研究方向：胃癌 经验分享：修回中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73b9380744, createdName=ms5000000214083952, createdTime=Tue Sep 24 18:46:38 CST 2024, time=2024-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129427, encodeId=52a9212942ea3, content=请教大家，进入step3一个半月了突然又回到step1，这是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Sun Apr 30 14:58:22 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2090962, encodeId=8dd320909622e, content=投稿命中率:25.0 偏重的研究方向：胃癌;生信;预后标志物 经验分享：生信文章，9.22日送审，9.82号直接拒稿，编辑一审这不过，理由优先级不够, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Thu Sep 29 10:07:38 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2217628, encodeId=94a9221e62862, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：三个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb86584693, createdName=ms4000001538615850, createdTime=Tue Jul 30 16:58:19 CST 2024, time=2024-07-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2118660, encodeId=d03e211866059, content=请问有最近投稿的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11248355803, createdName=ms6000001015003171, createdTime=Fri Mar 10 14:06:32 CST 2023, time=2023-03-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2115771, encodeId=34572115e716e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿时间偏慢，光分配编辑就快一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebf85455514, createdName=ms7000001555950151, createdTime=Tue Feb 21 19:37:23 CST 2023, time=2023-02-21, status=1, ipAttribution=浙江省)]

2023-02-21 ms7000001555950151 来自浙江省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：审稿时间偏慢，光分配编辑就快一个月了

178 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务